A Study of KIVU-305 in Participants With Locally Advanced or Metastatic Solid Tumors

计划入组 76 人 · 首次发布于 2026 年 4 月 22 日

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

计划入组 76 人 · 首次发布于 2025 年 11 月 14 日

Distal Radius Fractures in Adults: A Multi-Center Study in South Kivu

计划入组 192 人 · 首次发布于 2025 年 3 月 30 日

Glycopyranosyl lipid adjuvant (Revelation Biosciences)

Gut-Restricted TGF-Beta Receptor 1 Kinase Inhibitor (Enveda Biosciences)

PIN1(Larkspur Biosciences)

AURA BIOSCIENCES

India

Assembly Biosciences

United States

EUROMI BIOSCIENCES

France

Kivu Biosciences Secures $92M to Advance 'Kinder, Gentler' Antibody-Drug Conjugates

Kivu Bioscience Partners with Sterling Pharma for Phase 1 Manufacturing of Next-Generation ADC KIVU-107

Kivu Bioscience Initiates First-in-Human Trial of KIVU-107, Next-Generation PTK7-Targeting ADC for Advanced Solid Tumors